Back
EMCOR Group 10K Form
Buy
72
EME
EMCOR Group
Last Price:
527.06
Seasonality Move:
7.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | EME/EMCOR Group Quarterly |
| 2023-10-26 | 10Q | EME/EMCOR Group Quarterly |
| 2023-07-27 | 10Q | EME/EMCOR Group Quarterly |
| 2023-04-27 | 10Q | EME/EMCOR Group Quarterly |
| 2022-10-27 | 10Q | EME/EMCOR Group Quarterly |
| 2022-07-28 | 10Q | EME/EMCOR Group Quarterly |
Receive EME News And Ratings
See the #1 stock for the next 7 days that we like better than EME
EME Financial Statistics
Sales & Book Value
| Annual Sales: | $12.58B |
|---|---|
| Cash Flow: | $508.73M |
| Price / Cash Flow: | 18.45 |
| Annual Sales: | $59.96 |
| Price / Book: | 8.35 |
Profitability
| EPS (TTM): | 19.68000 |
|---|---|
| Net Income (TTM): | $926.5M |
| Gross Margin: | $2.09B |
| Return on Equity: | 35.99% |
| Return on Assets: | 13.66% |
EMCOR Group Earnings Forecast
Key EMCOR Group Financial Ratios
- The Gross Profit Margin over the past 30 years for EME is 16.60%.
- The Selling, General & Administrative Expenses for EME have been equal to 9.63% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 2.72% of Operating Income.
- The Net Earning history of EME is 5.03% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 22 years.
EMCOR Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Construction & Engineering |
| Sector: | Industrials |
| Current Symbol: | EME |
| CUSIP: | 29084Q |
| Website: | emcorgroup.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.28 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 37.63 |
|---|---|
| Forward P/E Ratio: | 22.47 |
EME Technical Analysis vs Fundamental Analysis
Buy
72
EMCOR Group (EME)
is a Buy
Is EMCOR Group a Buy or a Sell?
-
EMCOR Group stock is rated a Buy
The current EMCOR Group [EME] share price is $515.82. The Score for EME is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.